Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126146921 | 12614692 | 1 | I | 20160627 | 20160718 | 20160802 | 20160802 | EXP | US-BAYER-2016-140843 | BAYER | 63.00 | YR | A | F | Y | 0.00000 | 20160802 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126146921 | 12614692 | 1 | PS | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 4 MIU, QOD | 52196A | 103471 | 4 | MIU | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD | |||||
| 126146921 | 12614692 | 2 | SS | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 0.50 ML, UNK | 52196A | 103471 | .5 | ML | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD | |||||
| 126146921 | 12614692 | 3 | SS | BETACONNECT | DEVICE | 1 | 0 | ||||||||||||
| 126146921 | 12614692 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 126146921 | 12614692 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126146921 | 12614692 | 6 | C | POTASSIUM [POTASSIUM] | 2 | 0 | |||||||||||||
| 126146921 | 12614692 | 7 | C | CELEBREX | CELECOXIB | 1 | 0 | ||||||||||||
| 126146921 | 12614692 | 8 | C | COLCHICINE. | COLCHICINE | 1 | 0 | ||||||||||||
| 126146921 | 12614692 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 126146921 | 12614692 | 10 | C | BACLOFEN. | BACLOFEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126146921 | 12614692 | 1 | Relapsing-remitting multiple sclerosis |
| 126146921 | 12614692 | 2 | Relapsing-remitting multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126146921 | 12614692 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126146921 | 12614692 | Chills | |
| 126146921 | 12614692 | Device malfunction | |
| 126146921 | 12614692 | Drug dose omission | |
| 126146921 | 12614692 | Gait disturbance | |
| 126146921 | 12614692 | Injection site rash | |
| 126146921 | 12614692 | Mobility decreased | |
| 126146921 | 12614692 | Pain in extremity | |
| 126146921 | 12614692 | Pruritus generalised | |
| 126146921 | 12614692 | Pyrexia | |
| 126146921 | 12614692 | Urticaria | |
| 126146921 | 12614692 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126146921 | 12614692 | 1 | 20160623 | 0 | ||
| 126146921 | 12614692 | 2 | 20160801 | 0 |